Amalgam Rx

About:

Amalgam Rx is a digital health company that combines clinical and behavioral interventions to support patients, providers, & life sciences.

Website: http://amalgamrx.com/

Top Investors: Supermorpheus, Novo Nordisk, Mentors Fund, CVS Health Ventures

Description:

Amalgam Rx is the leader in bringing providers, life sciences, and digital solutions together. For more than 15 years, our team has been reimagining care delivery and creating lasting change across the chronic care ecosystem. Working in partnership with many of the world’s leading life sciences companies, Amalgam Rx has built an innovative platform for rapidly developing and scaling digital solutions — delivered through a wide variety of business models. Our proven end-to-end methodology enables the entire life cycle from R&D to commercialization. Amalgam’s solutions have generated more than 5 billion RWE data points utilized by patients and providers on three continents. For more information on how Amalgam Rx’s regulated, clinically validated technologies bring patients and providers closer together, reduce costs for payers, and unlock sustained value for partners, visit amalgamrx.com.

Total Funding Amount:

$18.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wilmington, Delaware, United States

Founded Date:

2016-01-01

Contact Email:

contact(AT)amalgamrx.com

Founders:

Ryan Sysko, Suzanne Sysko Clough

Number of Employees:

51-100

Last Funding Date:

2023-10-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai